Artificial Intelligence (AI) is playing a significant role in the evolution of reproductive medicine, enhancing precision, efficiency, and personalisation in fertility treatments. Professor Ying Cheong, a leading figure in reproductive medicine and Professor at the University of Southampton, discussed these advancements at the 2025 Congress of the Asia Pacific Initiative on Reproduction. She highlighted how AI-driven tools are optimising ovarian stimulation, assisting in embryo selection, and streamlining fertility clinic workflows. Robotics-assisted micromanipulation, AI-enhanced incubators, and non-invasive preimplantation genetic testing (PGT) are further improving embryo assessment. Yet, she cautions that the technology should not replace clinical expertise and that ethical considerations must be taken into account. She also stressed the need for AI in reproductive medicine to be accessible to all, through open access AI platforms and public-private partnerships.